ReP USP - Resultado da busca

Artigo de periodico
Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer (2023)
Gardani, Carla Fernanda Furtado; Pedrazza, Eduardo Luiz; Paz, Victória Santos; Zanirati, Gabriele Goulart; Costa, Jaderson Costa da; Andrejew, Roberta ; Ulrich, Henning ; Scholl, Juliete Nathali ; Figueiró, Fabrício ; Rockenbach, Liliana ; Morrone, Fernanda Bueno
Fonte: Pharmaceuticals. Unidade: IQ
Assuntos: NEOPLASIAS PROSTÁTICAS, CITOMETRIA DE FLUXO, HIDRÓLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARDANI, Carla Fernanda Furtado et al. Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer. Pharmaceuticals, v. 16, p. 1-17 art. 1619, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/ph16111619. Acesso em: 03 out. 2024.
APA
Gardani, C. F. F., Pedrazza, E. L., Paz, V. S., Zanirati, G. G., Costa, J. C. da, Andrejew, R., et al. (2023). Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer. Pharmaceuticals, 16, 1-17 art. 1619. doi:10.3390/ph16111619
NLM
Gardani CFF, Pedrazza EL, Paz VS, Zanirati GG, Costa JC da, Andrejew R, Ulrich H, Scholl JN, Figueiró F, Rockenbach L, Morrone FB. Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer [Internet]. Pharmaceuticals. 2023 ; 16 1-17 art. 1619.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/ph16111619
Vancouver
Gardani CFF, Pedrazza EL, Paz VS, Zanirati GG, Costa JC da, Andrejew R, Ulrich H, Scholl JN, Figueiró F, Rockenbach L, Morrone FB. Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer [Internet]. Pharmaceuticals. 2023 ; 16 1-17 art. 1619.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/ph16111619
Artigo de periodico
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients (2022)
Pietrobon, Anna Julia ; Andrejew, Roberta ; Custodio, Ricardo Wesley Alberca ; Oliveira, Luana de Mendonça ; Scholl, Juliete Nathali ; Teixeira, Franciane Mouradian Emidio ; Brito, Cyro Alves de ; Glaser, Talita ; Kazmierski, Julia ; Goffinet, Christine ; Turdo, Anna Claudia; Yendo, Tatiana Mina ; Aoki, Valeria; Figueiró, Fabrício; Battastini, Ana Maria ; Ulrich, Henning ; Benard, Gil ; Duarte, Alberto José da Silva; Sato, Maria Notomi
Fonte: Frontiers in Immunology. Unidades: FM, IQ, ICB
Assuntos: COVID-19, PURINAS, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIETROBON, Anna Julia et al. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, v. 13, p. 1-12 art. 1012027, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1012027. Acesso em: 03 out. 2024.
APA
Pietrobon, A. J., Andrejew, R., Custodio, R. W. A., Oliveira, L. de M., Scholl, J. N., Teixeira, F. M. E., et al. (2022). Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, 13, 1-12 art. 1012027. doi:10.3389/fimmu.2022.1012027
NLM
Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2024 out. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027
Vancouver
Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2024 out. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027
Artigo de periodico
Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening (2020)
Federico, Leonardo Bruno ; Silva, Guilherme Martins da ; Dias, Amanda de Fraga; Figueiró, Fabrício; Battastini, Ana Maria Oliveira; Santos, Cleydson Breno Rodrigues dos; Costa, Luciano T.; Campos Rosa, Joaquín Maria; Silva, Carlos Henrique Tomich de Paula da
Fonte: International Journal of Biological Macromolecules. Unidades: FCFRP, FFCLRP
Assuntos: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEDERICO, Leonardo Bruno et al. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening. International Journal of Biological Macromolecules, v. 165, p. 3040-3050, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2020.10.136. Acesso em: 03 out. 2024.
APA
Federico, L. B., Silva, G. M. da, Dias, A. de F., Figueiró, F., Battastini, A. M. O., Santos, C. B. R. dos, et al. (2020). Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening. International Journal of Biological Macromolecules, 165, 3040-3050. doi:10.1016/j.ijbiomac.2020.10.136
NLM
Federico LB, Silva GM da, Dias A de F, Figueiró F, Battastini AMO, Santos CBR dos, Costa LT, Campos Rosa JM, Silva CHT de P da. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening [Internet]. International Journal of Biological Macromolecules. 2020 ; 165 3040-3050.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijbiomac.2020.10.136
Vancouver
Federico LB, Silva GM da, Dias A de F, Figueiró F, Battastini AMO, Santos CBR dos, Costa LT, Campos Rosa JM, Silva CHT de P da. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening [Internet]. International Journal of Biological Macromolecules. 2020 ; 165 3040-3050.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijbiomac.2020.10.136
Artigo de periodico
Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study (2017)
Bergamin, Letícia Scussel; Figueiró, Fabrício; Dietrich, Fabrícia; Manica, Fabiana de Mattos; Chiela, Eduardo C. Filippi; Mendes, Franciane Brackman; Jandrey, Elisa Helena Farias; Lopes, Daniela Vasconcelos; Oliveira, Francine H; Nascimento, Isis C; Ulrich, Henning ; Battastini, Ana Maria Oliveira
Fonte: European Journal of Pharmacology. Unidade: IQ
Assunto: GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERGAMIN, Letícia Scussel et al. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study. European Journal of Pharmacology, v. 811, p. 268-275, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2017.06.030. Acesso em: 03 out. 2024.
APA
Bergamin, L. S., Figueiró, F., Dietrich, F., Manica, F. de M., Chiela, E. C. F., Mendes, F. B., et al. (2017). Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study. European Journal of Pharmacology, 811, 268-275. doi:10.1016/j.ejphar.2017.06.030
NLM
Bergamin LS, Figueiró F, Dietrich F, Manica F de M, Chiela ECF, Mendes FB, Jandrey EHF, Lopes DV, Oliveira FH, Nascimento IC, Ulrich H, Battastini AMO. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study [Internet]. European Journal of Pharmacology. 2017 ; 811 268-275.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2017.06.030
Vancouver
Bergamin LS, Figueiró F, Dietrich F, Manica F de M, Chiela ECF, Mendes FB, Jandrey EHF, Lopes DV, Oliveira FH, Nascimento IC, Ulrich H, Battastini AMO. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study [Internet]. European Journal of Pharmacology. 2017 ; 811 268-275.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2017.06.030

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada